Loading…
Ken GriffinHeld
Citadel Advisors · Q2 2026
$162.42K
12.48K shares · 0.0% of portfolio
Angiodynamics Inc
Angiodynamics Inc (ANGO) is listed on NASDAQ and classified in Medical Instruments & Supplies, part of the Healthcare sector. It is headquartered in Latham, United States and has 632 employees. The company is worth $505.49M. Revenue was $320.17M in fiscal 2026, up 9.5% from the year before. It reported a net loss of $36.74M. The share price is 26.2% below its 52-week high of $16.29. 6 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Steve Cohen (Point72 Asset Management), at $39.84M. In that quarter, 2 of them opened or added to the position and 1 reduced it. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▼ -56.3% over 5Y.
today you would have $393.01▼ -60.7%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 17 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $11.24 | $12.84 | $9.16 | $7.84 | $13.77 | $27.58 | $15.33 | $16.01 | $20.13 | $16.63 | $16.87 | $12.14 | $19.01 | $17.16 | $10.99 | $14.81 | $15.37 | |
| P/E |
Seven formulas applied to the reported numbers, each with its assumption next to the result. None of them predicts a price.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Cash flow growing 5.0% a year for 10 years, discounted at 10%, then 2.5% forever.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| DRUGBright Minds Biosciences Inc | $51.30 | — | 2.3x | 0.00% | -13.63% | $506.03M |
| SSIISS Innovations International, Inc. | $2.53 | — | 9.5x | 0.00% | -26.06% | $507.24M |
| SGHTSight Sciences, Inc. | $9.09 | — | 9.4x | 0.00% | -48.42% | $500.75M |
| ARVNArvinas Inc | $7.72 |
| 45.7x |
| — |
| — |
| — |
| — |
| — |
| — |
| — |
| 9.8x |
| 45.7x |
| 118.8x |
| — |
| — |
| 271.6x |
| — |
| — |
| 46.3x |
| 30.7x |
| P/S | 1.8x | 1.5x | 1.8x | 1.2x | 0.9x | 1.7x | 3.6x | 2.2x | 2.2x | 2.8x | 2.3x | 1.7x | 1.2x | 1.9x | 1.8x | 1.7x | 1.7x | 1.8x |
| P/B | 1.2x | 2.7x | 2.9x | 1.8x | 0.8x | 1.3x | 2.4x | 1.3x | 1.0x | 1.4x | 1.2x | 1.2x | 0.8x | 1.3x | 1.1x | 0.7x | 0.9x | 1.0x |
| EPS | -$0.88 | -$0.83 | -$4.59 | -$1.33 | -$0.68 | -$0.82 | -$4.39 | $1.64 | $0.44 | $0.14 | -$1.21 | -$0.09 | $0.07 | -$0.03 | -$0.20 | $0.32 | $0.50 |
| Profit margin | -2.40% | -11.48% | -11.62% | -60.66% | -15.48% | -8.40% | -10.84% | -63.14% | 22.67% | 6.24% | 1.86% | -12.32% | -0.95% | 0.66% | -0.31% | -2.40% | 3.75% | 5.70% |
| ROE | -1.02% | -21.51% | -18.58% | -89.67% | -13.86% | -6.25% | -7.18% | -36.67% | 9.98% | 3.01% | 0.97% | -8.59% | -0.62% | 0.44% | -0.20% | -1.02% | 1.99% | 3.15% |
Median of the years shown; P/E years above 200x are left out.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
The average of the method families that answered, not of the seven numbers: four of the seven start from the same earnings per share.
1 methods answered, across 1 families.
Room for errors in the reported numbers.
-87.6% from the average.
Models, not forecasts, and not investment advice. How each formula works →
| 28.6x |
| 0.9x |
| 0.00% |
| 1.59% |
| $498.1M |
| EVOEvotec SE | $1.38 | — | 0.7x | 0.00% | -26.07% | $490.44M |
| EOLSEvolus, Inc. | $7.41 | — | — | 0.00% | — | $489.43M |